Heghine Khachatryan – Outcomes Improve When Care is Planned, Coordinated, and Patient-Centered: New RPTH Study
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by RPTH Journal on LinkedIn:
“Multidisciplinary perinatal care for women with bleeding disorders — a clinical imperative
Women with inherited and acquired bleeding disorders remain at increased risk of hemorrhagic complications throughout pregnancy, delivery, and the postpartum period. A recent publication in Research and Practice in Thrombosis and Haemostasis (RPTH) underscores a crucial message: outcomes improve when care is planned, coordinated, and patient-centered.
Key takeaways for clinical practice:
- Early identification and pregnancy-specific risk stratification
- Structured, individualized care plans spanning antenatal, intrapartum, and postpartum phases
- Close collaboration between hematology, obstetrics, anesthesia, neonatology, and nursing
- Validation of patients’ lived experiences, reducing anxiety and improving adherence
- Continuity of care to optimize outcomes in subsequent pregnancies
This framework resonates strongly with daily practice in specialized hemostasis centers and highlights the value of multidisciplinary teams in translating evidence into safer maternal care.
Investing in coordinated perinatal pathways is not optional—it is fundamental to equity, safety, and quality in women’s health.”
Quoting RPTH Journal’s post:
“Women with bleeding disorders are at increased risk of bleeding during the perinatal period – how can clinicians help?
This study from Vanessa Giuliano and team show that multidisciplinary care and individualized care plans improve confidence and empowerment and support advocacy-based, patient-centered care.
Read more about it here.”
Title: Multidisciplinary perinatal care for women with bleeding disorders
Authors: Vanessa Giuliano, Natalya E. O’Neill, Vincent So, Shamshah Aratia, Shalene Wong, Allison Rupnaraine, Rebecca Sampat, Filomena Meffe, Jillian M. Baker, Jeffrey Wassermann, Grace H. Tang, Michelle Sholzberg
Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV